Faculty Publications

Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study

Kondagunta GV, Hudes G, Figlin R, Wilding G, Hariharan S, Kempin S, Fayyad R, Hoosen S, Motzer RJ

Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study

EJC Supplements. 2007 Sep;5(4):305.

Abstract

Last updated on Saturday, November 21, 2009